{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T04:46:50Z","timestamp":1793767610127,"version":"4.6.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T00:00:00Z","timestamp":1670457600000},"content-version":"vor","delay-in-days":6307,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["amjtransplant.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Transplantation"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1111\/j.1600-6143.2005.01005.x","type":"journal-article","created":{"date-parts":[[2005,8,8]],"date-time":"2005-08-08T05:00:17Z","timestamp":1123477217000},"page":"2236-2243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":129,"title":["Combined Therapy with Atorvastatin and Calcineurin Inhibitors: No Interactions with Tacrolimus"],"prefix":"10.1016","volume":"5","author":[{"given":"W.P.D","family":"Lemahieu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Asberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Verbeke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Holdaas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Vanrenterghem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.D","family":"Maes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1600-6143.2005.01005.x_bib1","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0140-6736(00)02456-9","article-title":"Premature cardiovascular disease in chronic renal failure","volume":"356","author":"Baigent","year":"2000","journal-title":"Lancet"},{"key":"10.1111\/j.1600-6143.2005.01005.x_bib2","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1097\/01.ASN.0000083008.25305.67","article-title":"Early renal insufficiency and hospitalized heart disease after renal transplantation in the era of modern immunosuppression","volume":"14","author":"Abbott","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"10.1111\/j.1600-6143.2005.01005.x_bib3","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/S0140-6736(03)13638-0","article-title":"Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo\u2010controlled trial","volume":"361","author":"Holdaas","year":"2003","journal-title":"Lancet"},{"key":"10.1111\/j.1600-6143.2005.01005.x_bib4","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199511163332001","article-title":"Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group","volume":"333","author":"Shepherd","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2005.01005.x_bib5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF heart protection study of cholesterol lowering with simvastatin in 20,536 high\u2010risk individuals: a randomised placebo\u2010controlled trial","volume":"360","year":"2002","journal-title":"Lancet"},{"key":"10.1111\/j.1600-6143.2005.01005.x_bib6","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0140-6736(02)11600-X","article-title":"PROspective Study of Pravastatin in the Elderly at Risk. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial","volume":"360","author":"Shepherd","year":"2002","journal-title":"Lancet"},{"key":"10.1111\/j.1600-6143.2005.01005.x_bib7","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0140-6736(03)12948-0","volume":"361","author":"Sever","year":"2003","journal-title":"Lancet"},{"key":"10.1111\/j.1600-6143.2005.01005.x_bib8","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/archinte.163.5.553","article-title":"Risk for myopathy with statin therapy in high\u2010risk patients","volume":"163","author":"Ballantyne","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1600-6143.2005.01005.x_bib9","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1345\/aph.1A289","article-title":"FDA adverse event reports on statin\u2010associated rhabdomyolysis","volume":"36","author":"Omar","year":"2002","journal-title":"Ann Pharmacother"},{"key":"10.1111\/j.1600-6143.2005.01005.x_bib10","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.clpt.2004.07.008","article-title":"Substantially elevated levels of atorvastatin and metabolites in cyclosporine\u2010treated renal transplant recipients","volume":"76","author":"Hermann","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/j.1600-6143.2005.01005.x_bib11","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.2165\/00003495-200161130-00006","article-title":"Cyclosporin: an updated review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion\u2010based formulation (neoral) 1 in organ transplantation","volume":"61","author":"Dunn","year":"2001","journal-title":"Drugs"},{"key":"10.1111\/j.1600-6143.2005.01005.x_bib12","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2165\/00003495-200363040-00003","article-title":"Interactions between cyclosporin and lipid\u2010lowering drugs: implications for organ transplant recipients","volume":"63","author":"Asberg","year":"2003","journal-title":"Drugs"},{"key":"10.1111\/j.1600-6143.2005.01005.x_bib13","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00210-003-0814-4","article-title":"Characterization of the transport of the bicyclic peptide phalloidin by human hepatic transport proteins","volume":"368","author":"Fehrenbach","year":"2003","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1111\/j.1600-6143.2005.01005.x_bib14","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2165\/00003088-200241110-00003","article-title":"Mechanisms of clinically relevant drug interactions associated with tacrolimus","volume":"41","author":"Christians","year":"2002","journal-title":"Clin Pharmacokinet"},{"key":"10.1111\/j.1600-6143.2005.01005.x_bib15","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0021-9150(01)00438-5","article-title":"Changes in lipid metabolism and effect of simvastatin in renal transplant recipients induced by cyclosporine or tacrolimus","volume":"158","author":"Ichimaru","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1111\/j.1600-6143.2005.01005.x_bib16","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.clpt.2003.09.011","article-title":"Pharmacokinetics and pharmacodynamics of pravastatin in pediatric and adolescent cardiac transplant recipients on a regimen of triple immunosuppression","volume":"75","author":"Hedman","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/j.1600-6143.2005.01005.x_bib17","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1111\/j.1600-6143.2004.00539.x","article-title":"CYP3A4 and P\u2010glycoprotein activity in healthy controls and transplant patients on cyclosporin vs. tacrolimus vs. sirolimus","volume":"4","author":"Lemahieu","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2005.01005.x_bib18","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1056\/NEJMoa042000","article-title":"Reversal of atherosclerosis with aggressive lipid lowering (REVERSAL) investigators. Statin therapy, LDL cholesterol, C\u2010reactive protein, and coronary artery disease","volume":"352","author":"Nissen","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2005.01005.x_bib19","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa042378","article-title":"Pravastatin or atorvastatin evaluation and infection therapy\u2014thrombolysis in myocardial infarction 22 (PROVE IT\u2010TIMI 22) investigators. C\u2010reactive protein levels and outcomes after statin therapy","volume":"352","author":"Ridker","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1600-6143.2005.01005.x_bib20","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/(SICI)1097-0231(19990615)13:11<1003::AID-RCM597>3.0.CO;2-L","article-title":"Quantitation of the acid and lactone forms of atorvastatin and its biotransformation products in human serum by high\u2010performance liquid chromatography with electrospray tandem mass spectrometry","volume":"13","author":"Jemal","year":"1999","journal-title":"Rapid Commun Mass Spectrom"},{"key":"10.1111\/j.1600-6143.2005.01005.x_bib21","unstructured":"Determination of atorvastatin and metabolites in human plasma with solid phase extraction followed by LC-tandem MS. Anal Bioanal Chem"},{"key":"10.1111\/j.1600-6143.2005.01005.x_bib22","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1152\/ajpgi.00028.2003","article-title":"Measurement of hepatic and intestinal CYP 3A4 and P\u2010glycoprotein activity by means of a combined po and iv C14 Erythromycin breath and urine test","volume":"285","author":"Lemahieu","year":"2003","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1111\/j.1600-6143.2005.01005.x_bib23","first-page":"931","article-title":"Aminopyrine breath test: development of a 13C\u2010breath test for quantitative assessment of liver function in humans","volume":"42","author":"Mion","year":"1995","journal-title":"Hepatogastroenterology"},{"key":"10.1111\/j.1600-6143.2005.01005.x_bib24","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1053\/ajkd.2002.34927","article-title":"Patient survival after renal transplantation III: the effects of statins","volume":"40","author":"Cosio","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"10.1111\/j.1600-6143.2005.01005.x_bib25","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1034\/j.1600-6143.2001.10415.x","article-title":"Bilateral pharmacokinetic interaction between cyclosporine A and atorvastatin in renal transplant recipients","volume":"1","author":"Asberg","year":"2001","journal-title":"Am J Transplant"},{"key":"10.1111\/j.1600-6143.2005.01005.x_bib26","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/mc.2940130302","article-title":"Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P\u2010glycoprotein: implications for drug delivery and activity in cancer chemotherapy","volume":"13","author":"Wacher","year":"1995","journal-title":"Mol Carcinog"},{"key":"10.1111\/j.1600-6143.2005.01005.x_bib27","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1124\/dmd.31.5.533","article-title":"Regulation of CYP3A4 expression in human hepatocytes by pharmaceuticals and natural products","volume":"31","author":"Raucy","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1111\/j.1600-6143.2005.01005.x_bib28","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.clpt.2003.10.008","article-title":"Cytochrome P450 3A4 and P\u2010glycoprotein expression in human small intestinal enterocytes and hepatocytes: a comparative analysis in paired tissue specimens","volume":"75","author":"Von Richter","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/j.1600-6143.2005.01005.x_bib29","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S1053-2498(01)00251-0","article-title":"Safety and efficacy of pravastatin therapy for the prevention of hyperlipidemia in pediatric and adolescent cardiac transplant recipients","volume":"20","author":"Penson","year":"2001","journal-title":"J Heart Lung Transplant"}],"container-title":["American Journal of Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-6143.2005.01005.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522127449?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1600613522127449?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-6143.2005.01005.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T04:34:56Z","timestamp":1761626096000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1600613522127449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["S1600613522127449"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-6143.2005.01005.x","relation":{},"ISSN":["1600-6135"],"issn-type":[{"value":"1600-6135","type":"print"}],"subject":[],"published":{"date-parts":[[2005,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combined Therapy with Atorvastatin and Calcineurin Inhibitors: No Interactions with Tacrolimus","name":"articletitle","label":"Article Title"},{"value":"American Journal of Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1600-6143.2005.01005.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. All rights reserved. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}